Budesonide and Injectafer drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Budesonide (budesonide) and Injectafer (ferric carboxymaltose). Common drug interactions include pancreatitis among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Budesonide and Injectafer. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Injectafer?

Injectafer has active ingredients of ferric carboxymaltose. eHealthMe is studying from 3,270 Injectafer users. Check the latest studies of Injectafer.



On Jul, 17, 2026

14 people who take Budesonide and Injectafer together, and have interactions are studied.

Budesonide and Injectafer drug interactions.

What are the common drug interactions of Budesonide and Injectafer, by gender? *:

female:

  1. Pancreatitis (inflammation of pancreas)
  2. Chest discomfort
  3. Chronic kidney disease
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Drug hypersensitivity
  6. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  7. Plasma cell myeloma (cancer that begins in plasma cells)
  8. Stridor

male:

  1. Diarrhoea
  2. Anaemia (lack of blood)
  3. Non-small cell lung cancer (type of epithelial lung cancer)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Peripheral swelling
  6. Pneumonia
  7. Presyncope
  8. Weight decreased
  9. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  10. Abdominal distension

What are the common drug interactions of Budesonide and Injectafer, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chest discomfort

30-39:

  1. Drug hypersensitivity
  2. Dyspnoea (difficult or laboured respiration)
  3. Presyncope
  4. Stridor

40-49:

  1. Pancreatitis (inflammation of pancreas)

50-59:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Flatulence (flatus expelled through the anus)
  4. Frequent bowel movements
  5. Iron deficiency
  6. Peripheral swelling
  7. Pneumonia
  8. Weight decreased
  9. Abdominal distension

60+:

  1. Anaemia (lack of blood)
  2. Diarrhoea
  3. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  4. Chronic kidney disease
  5. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  6. Ilium fracture
  7. Non-small cell lung cancer (type of epithelial lung cancer)
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Plasma cell myeloma (cancer that begins in plasma cells)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 28.57%
  2. Pain: 3 people, 21.43%
  3. Anaemia (lack of blood): 3 people, 21.43%
  4. Iron Deficiency Anaemia: 3 people, 21.43%
  5. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 14.29%
  6. Iron Deficiency: 2 people, 14.29%
  7. Nausea (feeling of having an urge to vomit): 2 people, 14.29%
  8. Diarrhea: 2 people, 14.29%
  9. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 1 person, 7.14%
  10. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and Injectafer?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Budesonide and Injectafer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Injectafer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Budesonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Injectafer and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and ferric carboxymaltose (the active ingredients of Budesonide and Injectafer, respectively), and Budesonide and Injectafer (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: